These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 23770372)

  • 1. Reply by author.
    J Urol; 2013 Sep; 190(3):1140. PubMed ID: 23770372
    [No Abstract]   [Full Text] [Related]  

  • 2. To biopsy or not to biopsy: minimizing the risk of prostate needle biopsy.
    Kibel AS
    J Urol; 2013 Mar; 189(3):796-7. PubMed ID: 23246850
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: To biopsy or not to biopsy: minimizing the risk of prostate needle biopsy: A. S. Kibel J Urol 2013; 189: 796-797.
    Horan AH
    J Urol; 2013 Sep; 190(3):1139. PubMed ID: 23583228
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply by authors.
    J Urol; 2013 Oct; 190(4):1440. PubMed ID: 23886879
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: Is repeat prostate biopsy associated with a greater risk of hospitalization? Data from SEER-Medicare: S. Loeb, H. B. Carter, S. I. Berndt, W. Ricker and E. M. Schaeffer J Urol 2013; 189: 867-870.
    Singh I; Gautam L
    J Urol; 2013 Oct; 190(4):1439-40. PubMed ID: 23886882
    [No Abstract]   [Full Text] [Related]  

  • 6. The number of cores taken in patients diagnosed with a single microfocus at initial biopsy is a major predictor of insignificant prostate cancer.
    Villa L; Capitanio U; Briganti A; Abdollah F; Suardi N; Salonia A; Gallina A; Freschi M; Russo A; Castiglione F; Bianchi M; Rigatti P; Montorsi F; Scattoni V
    J Urol; 2013 Mar; 189(3):854-9. PubMed ID: 23022004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Commentary on "Is repeat prostate biopsy associated with a greater risk of hospitalization? Data from SEER-Medicare." Loeb S, Carter HB, Berndt SI, Ricker W, Schaeffer EM, Department of Urology, New York University, New York, NY. J Urol 2013; 189(3):867-70. [Epub 2012 Oct 9]. doi: 10.1016/j.juro.2012.10.005.
    Eggener S
    Urol Oncol; 2014 Aug; 32(6):935-6. PubMed ID: 25087672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The pathologist's role: to diagnose prostatic cancer and determine prognosis].
    Egevad L
    Lakartidningen; 2012 Feb 22-28; 109(8):403-6. PubMed ID: 22509665
    [No Abstract]   [Full Text] [Related]  

  • 9. Editorial comment.
    Labanaris AP
    J Urol; 2013 Mar; 189(3):866. PubMed ID: 23261235
    [No Abstract]   [Full Text] [Related]  

  • 10. Prostate cancer polar localization on core biopsy predicts pathologic stage.
    Hensley PJ; Bailey LR; Purdom MS; Davenport DL; Strup SE
    Can J Urol; 2016 Dec; 23(6):8551-8556. PubMed ID: 27995850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is repeat prostate biopsy associated with a greater risk of hospitalization? Data from SEER-Medicare.
    Loeb S; Carter HB; Berndt SI; Ricker W; Schaeffer EM
    J Urol; 2013 Mar; 189(3):867-70. PubMed ID: 23063634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Words of wisdom: re: transperineal magnetic resonance image targeted prostate biopsy versus transperineal template prostate biopsy in the detection of clinically significant prostate cancer.
    Ravery V
    Eur Urol; 2013 Aug; 64(2):337. PubMed ID: 23830225
    [No Abstract]   [Full Text] [Related]  

  • 13. Gleason grading of prostate cancer in needle biopsies vs. radical prostatectomy specimens.
    Vidal-Jimenez A
    Anal Quant Cytol Histol; 2006 Dec; 28(6):340-1. PubMed ID: 17225300
    [No Abstract]   [Full Text] [Related]  

  • 14. Extent of cancer of less than 50% in any prostate needle biopsy core: how many millimeters are there?
    Montironi R; Scarpelli M; Mazzucchelli R; Cheng L; Lopez-Beltran A; Montorsi F
    Eur Urol; 2012 Apr; 61(4):751-6. PubMed ID: 22239991
    [No Abstract]   [Full Text] [Related]  

  • 15. The utility of artificial intelligence in the assessment of prostate pathology.
    Egevad L; Ström P; Kartasalo K; Olsson H; Samaratunga H; Delahunt B; Eklund M
    Histopathology; 2020 May; 76(6):790-792. PubMed ID: 32402150
    [No Abstract]   [Full Text] [Related]  

  • 16. Re: Transperineal template-guided saturation biopsy using a modified technique: outcome of 270 cases requiring repeat prostate biopsy.
    Taneja SS
    J Urol; 2013 Oct; 190(4):1245-6. PubMed ID: 24029308
    [No Abstract]   [Full Text] [Related]  

  • 17. Value of transition zone biopsy in active surveillance of prostate cancer.
    Wang CC; Carter HB; Epstein JI
    J Urol; 2014 Jun; 191(6):1755-9. PubMed ID: 24316092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of the 2005 International Society of Urological Pathology Gleason Grading System in prostate biopsy and radical prostatectomy specimens.
    Trpkov K; Zhang J
    BJU Int; 2009 Sep; 104(5):722-3. PubMed ID: 19689580
    [No Abstract]   [Full Text] [Related]  

  • 19. Gleason grading of prostate carcinoma in needle biopsies vs. radical prostatectomy specimens.
    Mazzucchelli R; Barbisan F; Tarquini LM; Filosa A; Campanini N; Galosi AB
    Anal Quant Cytol Histol; 2005 Jun; 27(3):125-33. PubMed ID: 16121633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer grading: recent developments and future directions.
    Delahunt B; Egevad L; Grignon DJ; Srigley JR; Samaratunga H
    BJU Int; 2016 Apr; 117 Suppl 4():7-8. PubMed ID: 27094970
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.